Περίληψη:
We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed. © 2020 Elsevier B.V.
Συγγραφείς:
Arenas, M.
Selek, U.
Kaidar-Person, O.
Perrucci, E.
Montero Luis, A.
Boersma, L.
Coles, C.
Offersen, B.
Meattini, I.
Bölükbaşı, Y.
Leonardi, M.C.
Pfeffer, R.
Cutuli, B.
Vidali, C.
Franco, P.
Kouloulias, V.
Masiello, V.
Rivera, S.
Bourgier, C.
Ciabattoni, A.
Lancellotta, V.
Trigo, L.
Valentini, V.
Poortmans, P.
Aristei, C.
Λέξεις-κλειδιά:
breast cancer; breast reconstruction; cancer radiotherapy; cancer recurrence; cancer staging; clinical practice; consensus; evidence based medicine; human epidermal growth factor receptor 2 positive breast cancer; hypofractionated radiotherapy; internal mammary node radiation; intraductal carcinoma; lymph vessel metastasis; mastectomy; organs at risk; partial mastectomy; patient care; planning target volume; practice guideline; quality of life; questionnaire; Review; sentinel lymph node biopsy; systemic therapy; treatment duration; treatment indication; treatment outcome; tumor volume; whole breast irradiation; adjuvant radiotherapy; breast tumor; human; intraductal carcinoma; pathology; procedures, Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Humans; Mastectomy; Mastectomy, Segmental; Radiotherapy, Adjuvant
